🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, controlled, multicenter clinical study that enrolled ...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2026-05-01
Trial ID
NCT07560358
The study is a multicenter, open-label, randomized controlled clinical stud...
Status
Active Not Recruiting
Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Start Date
2021-07-20
Trial ID
NCT04928807
Treatments Being Tested
This is a phase II/III, multi-center, open-label, 3-arm, randomized control...
Status
Recruiting
Location
Beijing Friendship Hospital, Capital Medical University
Start Date
2022-04-01
Trial ID
NCT05245474
Treatments Being Tested
This is a multicenter, randomized, controlled phase III trial to evaluate t...
Status
Suspended
Location
Department of Radiation Oncology, Shandong Cancer Hospital and Institute
Start Date
2023-12-01
Trial ID
NCT06246344
To observe the efficacy and safety of hydrochloride anlotinib combined with...
Status
Unknown
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05772377
Treatments Being Tested
The study is being conducted to evaluation of the Efficacy and Safety of QL...
Status
Recruiting
Location
Shanghai Chest Hospital
Start Date
2025-10-23
Trial ID
NCT07091305
Treatments Being Tested
This is a single-center, single-arm, open-label, prospective phase 2 trial ...
Status
Completed
Location
Department of Internal Medicine, Yonsei University College of Medicine
Start Date
2014-12-03
Trial ID
NCT02425605
The goal of this study is to assess the safety and effectiveness of Dostarl...
Status
Recruiting
Location
GSK Investigational Site
Start Date
2024-03-21
Trial ID
NCT06256588
Treatments Being Tested
Nasopharyngeal carcinoma（NPC）is common malignant tumor in China. The incide...
Status
Completed
Location
Sichuan Cancer Hospital
Start Date
2022-03-26
Trial ID
NCT05292027
Treatments Being Tested
This is a prospective , single - arm clinical study , aiming to evaluate th...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-05-15
Trial ID
NCT06981858
Treatments Being Tested